IN-VITRO SCREENING OF THEAFLAVIN AND GINKGETIN ON A549 LUNG CANCER CELL LINE
Cancer is a complex, multi-gene, multi-step disease occurring as a result of a sequential accumulation of genetic and epigenetic changes. Death due to cancer rank second among all cause of death globally. Dysregulation of signaling pathway e.g. HGF/c-MET which were otherwise activated during embryonic development contributes to malignant transformation and metastasis in later phase of life. Phytochemicals due to their safety, low toxicity, and general availability are either taken as supplement or through dietary sources for cancer chemoprevention or supportive agent during the treatment of cancer. The present study therefore aim to screen in-silico inspired c-MET antagonist Theaflavin & Ginkgetin in-vitro on against A549 cell line along with their antiangiogenesis effect on chick embryo model.